Previous studies on the carcinogenesis of ESCC have mainly focused on genetic alterations including those in COX-2, BCL-2, p53, p16, cyclin D1, EGFR, VEGF, and E-cadherin [4], [18]. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.